TOFIDENCE
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97178316
- Registration number
- 7589164
- Mark type
- Stylized text
- Filed
- 17 Dec 2021
- Published for opposition
- 28 Jun 2022
- Registered
- 03 Dec 2024
- Attorney of record
- James A. Thomas
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation for the treatment of arthritis; antiinterleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production;
Owner
- N.V. ORGANON, OSS, NL
- BIOGEN INTERNATIONAL GMBH, BAAR, CH
- BIOGEN INTERNATIONAL GMBH, BAAR, CH
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
Prosecution history
- 24 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Apr 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 24 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Nov 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jul 2024 — USE AMENDMENT FILED
- 08 Nov 2024 — SOU EXTENSION 4 GRANTED